Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New HCA Patents From Renaissance & Glykon - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

New HCA Patents From Renaissance & Glykon

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Renaissance Herbs, Inc., Chatsworth, CA, has introduced new delivery modalities and innovative uses for HCA under an exclusive licensing agreement with Gly­kon Technologies Group, LLC. This a­greement incorporates 13 U.S. patents and patents pending, plus additional proprietary technology. Glykon Technologies Group discovered and holds the rights to make claims regarding the impact of HCA on the regulation of insulin and blood sugar (Syndrome X), modulation of leptin and glucocorticoids, improvements in bone mineralization, the regulation of immune function and inflammation. The company also has patented multiple technologies greatly expanding the range of available delivery forms for HCA as well as improving its assimilation and activity.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics